RXi Pharmaceuticals Announces Investor and Analyst Symposium

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

RXi Pharmaceuticals Corporation (OTC: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that it will hold its first Investor and Analyst Symposium.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC